Clinical Trials Logo

Clinical Trial Summary

The main objective of this study is to evaluate the efficacy of an acellular dermal matrix membrane to increase the peri-implant soft tissue thickness and to reduce marginal bone loss during non-submerged implant placement, as compared with the standard protocol for implant placement. The test hypothesis is that placing an acellular dermal matrix membrane simultaneous to implant placement in the posterior mandible, will increase the soft tissue thickness and consequently reduce the marginal bone level changes. The study is designed as a doubled-blind, parallel groups, randomized clinical trial with a 1-year follow-up


Clinical Trial Description

The study is designed as a doubled-blind, parallel groups, randomized clinical trial with a 1-year follow-up. The randomization sequence will be created using a computer-generated list by an independent researcher. Allocation concealment will be kept by means of opaque sealed envelopes that will be open by one of the researchers during surgery, and revealed to the operator immediately after implant insertion. All patients will receive standardized oral hygiene instructions consisting on the use of a manual or power-driven toothbrush and specific interdental brushes. Then, patients will be randomized to one of the following groups: - Test Group :Mucoperiosteal flaps will be raised and the conventional drilling sequence for implants will be implemented (Camlog Conelog Screw-Line Promote Plus implants). Implants will be placed 1 mm below the bone crest. The diameter of the implant will be in the range of 3.8 and 4.3 mm. Consecutively, 4 to 6 mm height healing abutments and the allogenic membrane (NovoMatrix®, BioHorizon) folded in two on top of the implant (secured with the healing abutment), will be placed. Finally, flaps will be sutured with 6/0 polypropylene monofilament. Patients will be instructed to rinse with 15 ml of 0.12% chlorhexidine (Perio-Aid tratamiento, Dentaid SL, Barcelona, Spain) 60 seconds twice per day until suture removal, that will take place 14 days later. Anti-inflammatory drugs will also be prescribed (Ibuprofen 600 mg every 8 hours upon patient´s needs) - Control Group: All the procedures will be the same as in the Test Group, with the only difference that no attempt to thicken the mucosa with the acellular dermal matrix will be performed. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05156294
Study type Interventional
Source Universidad Complutense de Madrid
Contact
Status Active, not recruiting
Phase Phase 3
Start date January 10, 2022
Completion date August 10, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT03459547 - Soft Peri-implant Tissue Around Different Abutment Materials N/A
Completed NCT05724706 - An Evaluation of Salivary Oxidant and Antioxidant Levels in Peri-implant Health and Disease
Completed NCT05494476 - Stability of the Marginal Bone Around Subcrestal Implants N/A
Completed NCT02625597 - Assessment of the Effects of Different Implant Abutment Occluding Materials on Dental Implant Health Parameters and Microbiology N/A
Active, not recruiting NCT03982615 - Impact of Laser-modified Abutment Topography on Peri-implant Mucosal Integration N/A
Completed NCT03501199 - Comparison of Different Materials Contribution to Implants Stability N/A
Recruiting NCT05924711 - "Association of Peri-implantitis and Maxillary Sinusitis: a Case-control Study".
Not yet recruiting NCT04299386 - Effect of Nanocrystal Gels on the Management of Peri-implant Diseases N/A
Recruiting NCT03524872 - Implant/Abutment Module Stability of Original vs Compatible Connections N/A
Completed NCT03041584 - Dental Implants Placed by Using a Drill Guide Versus Non-guided Placement. Follow-up Study N/A
Recruiting NCT04906161 - Vitamin D and Serum Calcium Level Insufficiency and Early Dental Implant Failure
Active, not recruiting NCT05595772 - Comparison of Two Different Types of Platelet Concentrate to Augment Bone Around Immediate Dental Implant N/A
Recruiting NCT06135506 - Artificial Intelligence/Computer Guided Ridge Splitting for Treating Horizontal Ridge Defects N/A
Completed NCT04082143 - CATER: Comprehensive Alveolar and Tooth Esthetic Replacement Phase 3
Completed NCT06131541 - Ridge Splitting With Implant Placement Using Autogenous Tooth Graft N/A